Explore our range of useful resources below, designed to support you with your decision making. There are files you can download to refer to later.

These documents contain links which will take you to external websites over which Novartis Pharmaceuticals UK Limited has no ownership or control. Novartis Pharmaceuticals UK Limited accepts no responsibility for the content, accuracy, or your use of linked websites.


The Forgotten Many: A 2020 vision for SPMS

Watch this insightful video from Professor Gavin Giovannoni (Professor of Neurology, Barts and the London School of Medicine and Dentistry) and Sue Thomas (Report Author and Co-Founder, MS Academy), summarising the key learnings from an SPMS burden report.

Report detailing the impact of SPMS on patients and the healthcare system, putting forward a number of recommendations identified by a group of leading experts in the area, that can potentially help transform the delivery of SPMS care and patient outcomes.

Download resource

placeholder image

Virtual MDT experience sharing

This supplement describes the challenges faced by an established regional service, and how the service was strengthened by moving to a virtual MDT model – with the aim of sharing the key learnings to help others considering a similar change.

Download resource

placeholder image

GIRFT and RightCare in MS

Learn more about how the RightCare and GIRFT policies are relevant and influential in MS.

Download resource


GIRFT, getting it right first time; MDT, multidisciplinary team; MEGS, medical and educational goods and services; MS, multiple sclerosis; SPMS, secondary progressive multiple sclerosis.

Rate this content: 
Average: 5 (1 vote)
UK | May 2021 | 119829

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]